{"id":"https://openalex.org/W2970102285","doi":null,"title":"Mechanisms of Globin Regulation and Modeling Fetal Hemoglobin Reactivation","display_name":"Mechanisms of Globin Regulation and Modeling Fetal Hemoglobin Reactivation","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W2970102285","mag":"2970102285"},"language":"en","primary_location":{"id":"mag:2970102285","doi":null,"is_oa":false,"landing_page_url":"http://www.bloodjournal.org/content/130/Suppl_1/4768?sso-checked=true","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050972465","display_name":"Billy Stuart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094323","display_name":"Fulcrum Therapeutics (United States)","ror":"https://ror.org/006f8jv23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Billy Stuart","raw_affiliation_strings":["Fulcrum Therapeutics, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fulcrum Therapeutics, Cambridge, MA","institution_ids":["https://openalex.org/I4210094323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041449809","display_name":"Michael D. Cameron","orcid":"https://orcid.org/0000-0003-3154-4775","observed_orcids":["https://orcid.org/0000-0003-3154-4775"]},"institutions":[{"id":"https://openalex.org/I4210094323","display_name":"Fulcrum Therapeutics (United States)","ror":"https://ror.org/006f8jv23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael D. Cameron","raw_affiliation_strings":["Fulcrum Therapeutics, Cambridge, MA"],"raw_orcid":"https://orcid.org/0000-0003-3154-4775","affiliations":[{"raw_affiliation_string":"Fulcrum Therapeutics, Cambridge, MA","institution_ids":["https://openalex.org/I4210094323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060381167","display_name":"Angela M. Cacace","orcid":"https://orcid.org/0000-0001-8013-4022","observed_orcids":["https://orcid.org/0000-0001-8013-4022"]},"institutions":[{"id":"https://openalex.org/I4210094323","display_name":"Fulcrum Therapeutics (United States)","ror":"https://ror.org/006f8jv23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Cacace","raw_affiliation_strings":["Fulcrum Therapeutics, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fulcrum Therapeutics, Cambridge, MA","institution_ids":["https://openalex.org/I4210094323"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042183595","display_name":"Peter B. Rahl","orcid":"https://orcid.org/0000-0001-8932-9483","observed_orcids":["https://orcid.org/0000-0001-8932-9483"]},"institutions":[{"id":"https://openalex.org/I4210094323","display_name":"Fulcrum Therapeutics (United States)","ror":"https://ror.org/006f8jv23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter B. Rahl","raw_affiliation_strings":["Fulcrum Therapeutics, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fulcrum Therapeutics, Cambridge, MA","institution_ids":["https://openalex.org/I4210094323"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210094323"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.28763459,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"130","issue":null,"first_page":"4768","last_page":"4768"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12094","display_name":"Hemoglobin structure and function","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fetal-hemoglobin-reactivation","display_name":"fetal hemoglobin reactivation","score":0.9340000152587891},{"id":"https://openalex.org/keywords/beta-globin","display_name":"beta-globin","score":0.8989999890327454},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9269999861717224},{"id":"https://openalex.org/keywords/beta-thalassemia","display_name":"beta-thalassemia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/globin-gene-regulation","display_name":"globin gene regulation","score":0.847000002861023},{"id":"https://openalex.org/keywords/chromatin-modification","display_name":"chromatin modification","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C2776317666","wikidata":"https://www.wikidata.org/wiki/Q2496436","display_name":"Fetal hemoglobin","level":4,"score":0.7561081051826477},{"id":"https://openalex.org/C125996951","wikidata":"https://www.wikidata.org/wiki/Q412234","display_name":"Globin","level":3,"score":0.6852375864982605},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6826446056365967},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.5814444422721863},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.5732153654098511},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.4671548902988434},{"id":"https://openalex.org/C2777799968","wikidata":"https://www.wikidata.org/wiki/Q185137","display_name":"Thalassemia","level":2,"score":0.4545319676399231},{"id":"https://openalex.org/C165864922","wikidata":"https://www.wikidata.org/wiki/Q411391","display_name":"Regulation of gene expression","level":3,"score":0.41555672883987427},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.41183626651763916},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.411584734916687},{"id":"https://openalex.org/C172680121","wikidata":"https://www.wikidata.org/wiki/Q26513","display_name":"Fetus","level":3,"score":0.39854198694229126},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3782792091369629},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.358387291431427},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.34711623191833496},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17036652565002441},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.06332498788833618}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2970102285","doi":null,"is_oa":false,"landing_page_url":"http://www.bloodjournal.org/content/130/Suppl_1/4768?sso-checked=true","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2988170498","https://openalex.org/W2026207988","https://openalex.org/W1921966331","https://openalex.org/W2563600223","https://openalex.org/W2582910449","https://openalex.org/W2511851487","https://openalex.org/W4389228970","https://openalex.org/W3010666650","https://openalex.org/W2979794493","https://openalex.org/W7221075695"],"abstract_inverted_index":{"Red":[0],"blood":[1],"cell":[2],"disorders":[3,39],"like":[4],"Sickle":[5],"Cell":[6],"Disease":[7],"(SCD)":[8],"and":[9,115,187],"\u03b2-thalassemias":[10],"are":[11,214],"caused":[12],"by":[13,40],"alterations":[14],"within":[15],"the":[16,19,45,61,74,86,129,138,154,159,174,200],"gene":[17,229],"for":[18,126],"hemoglobin":[20,30,47,176],"\u03b2":[21,113,163],"(HB\u03b2)":[22],"subunit.":[23,49,178],"An":[24],"anti-sickling":[25,87,130],"fetal":[26,62],"ortholog":[27,63,76,89],"of":[28,85,92,97,128,140,148,156,173,189,199,240],"HB\u03b2,":[29],"\u03b3":[31,88,109,131,141,161],"(HB\u03b3)":[32],"can":[33,204],"reverse":[34],"disease-related":[35],"pathophysiology":[36],"in":[37,60,73,143,171,219],"these":[38,227],"also":[41],"forming":[42],"complexes":[43],"with":[44,57,70,150,168],"required":[46],"\u03b1":[48,177],"Because":[50],"\u03b2-like":[51],"globin":[52,201,210,228],"expression":[53,84,110,114,164,172],"is":[54],"developmentally":[55],"regulated,":[56],"a":[58,98,122,144,169,216],"reduction":[59,170],"(\u03b3)":[64],"occurring":[65],"shortly":[66],"after":[67],"birth":[68],"concomitantly":[69],"an":[71],"increase":[72],"adult":[75],"(\u03b2),":[77],"it":[78],"has":[79,118],"been":[80,105,119],"postulated":[81],"that":[82,137,195],"maintaining":[83],"may":[90],"be":[91],"therapeutic":[93],"benefit.":[94],"Previously,":[95],"inhibitors":[96],"chromatin":[99],"modifying":[100],"enzyme":[101],"G9a/GLP":[102,117],"(G9a-i)":[103],"have":[104,135,193,205],"shown":[106],"to":[107,112,183,224,242],"upregulate":[108],"relative":[111],"therefore":[116,180],"proposed":[120],"as":[121],"reasonable":[123],"molecular":[124],"target":[125],"maintenance":[127],"ortholog.":[132],"However,":[133],"we":[134,213],"found":[136],"reactivation":[139],"occurs":[142,166],"narrow":[145],"concentration":[146],"range":[147],"G9a-i":[149],"higher":[151],"concentrations":[152],"reducing":[153],"levels":[155],"\u03b3.":[157],"Moreover,":[158],"enhanced":[160],"/":[162],"ratio":[165],"simultaneously":[167],"critical":[175],"We":[179,192],"set":[181],"out":[182],"identify":[184],"novel":[185],"modulators":[186],"targets":[188],"HB\u03b3":[190],"expression.":[191,211],"demonstrated":[194],"targeting":[196],"different":[197,207],"components":[198],"regulatory":[202],"network":[203],"profoundly":[206],"effects":[208],"on":[209],"Importantly,":[212],"utilizing":[215],"newly":[217],"developed":[218],"vitro":[220],"SCD":[221,232],"cellular":[222],"model":[223],"investigate":[225],"how":[226],"regulators":[230],"impact":[231],"pathophysiology.":[233],"Disclosures":[235],"No":[237],"relevant":[238],"conflicts":[239],"interest":[241],"declare.":[243]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-09-05T00:00:00"}